Härle P, Straub R H, Wiest R, Mayer A, Schölmerich J, Atzeni F, Carrabba M, Cutolo M, Sarzi-Puttini P
Laboratory of Neuroendocrinoimmunology, Department of Internal Medicine I, University Hospital Regensburg, Germany.
Ann Rheum Dis. 2006 Jan;65(1):51-6. doi: 10.1136/ard.2005.038059. Epub 2005 Jun 7.
To study in parallel the outflow of the sympathetic nervous system (SNS) and the hypothalamic-pituitary adrenal (HPA) axis tone in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
32 patients with SLE, 62 with RA, and 65 healthy subjects (HS) were included. To measure the tone of the HPA axis, plasma ACTH and serum cortisol were determined. Serum neuropeptide Y (NPY) was used to evaluate the sympathetic outflow.
Patients with SLE had increased NPY levels in comparison with HS, irrespective of prior prednisolone treatment (p<0.001). For patients with RA, only those with prednisolone treatment had increased NPY levels in comparison with HS (p = 0.016). Daily prednisolone dose correlated positively with serum NPY in RA (R(Rank) = 0.356, p = 0.039). In contrast, plasma ACTH levels were generally decreased significantly in comparison with HS in SLE with prednisolone, and in RA with/without prednisolone. Similarly, serum cortisol levels were also decreased in SLE with/without prednisolone, and in RA with prednisolone. The NPY/ACTH ratio was increased in SLE and RA, irrespective of prior prednisolone treatment. The NPY/cortisol ratio was increased in SLE with/without prednisolone, and in RA with prednisolone. Twelve weeks' anti-TNF antibody treatment with adalimumab did not decrease NPY levels in RA, irrespective of prednisolone treatment.
An increased outflow of the SNS was shown and a decreased tone of the HPA axis in patients with SLE and RA. Low levels of cortisol in relation to SNS neurotransmitters may be proinflammatory because cooperative anti-inflammatory coupling of the two endogenous response axes is missing.
平行研究系统性红斑狼疮(SLE)和类风湿关节炎(RA)患者交感神经系统(SNS)的传出情况以及下丘脑 - 垂体 - 肾上腺(HPA)轴的张力。
纳入32例SLE患者、62例RA患者和65名健康受试者(HS)。为测量HPA轴的张力,测定血浆促肾上腺皮质激素(ACTH)和血清皮质醇。血清神经肽Y(NPY)用于评估交感神经传出情况。
与HS相比,SLE患者的NPY水平升高,无论之前是否接受过泼尼松龙治疗(p<0.001)。对于RA患者,只有接受泼尼松龙治疗的患者与HS相比NPY水平升高(p = 0.016)。RA患者每日泼尼松龙剂量与血清NPY呈正相关(R(秩相关)= 0.356,p = 0.039)。相比之下,在接受泼尼松龙治疗的SLE患者以及接受或未接受泼尼松龙治疗的RA患者中,血浆ACTH水平与HS相比总体显著降低。同样,在接受或未接受泼尼松龙治疗的SLE患者以及接受泼尼松龙治疗的RA患者中,血清皮质醇水平也降低。无论之前是否接受过泼尼松龙治疗,SLE和RA患者的NPY/ACTH比值均升高。在接受或未接受泼尼松龙治疗的SLE患者以及接受泼尼松龙治疗的RA患者中,NPY/皮质醇比值升高。使用阿达木单抗进行12周的抗TNF抗体治疗,无论是否接受泼尼松龙治疗,均未降低RA患者的NPY水平。
SLE和RA患者显示出SNS传出增加以及HPA轴张力降低。与SNS神经递质相关的皮质醇水平较低可能具有促炎作用,因为这两个内源性反应轴的协同抗炎耦合缺失。